Getinge AB (publ)
GNGBF
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.37B
Close$
$17.18
26.5% downside
Current Fair Value
26.5% downsideOvervalued by 26.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.37 Billion |
|---|---|
| Enterprise Value | $15.42 Billion |
| Dividend Yield | $0.52 (1.88%) |
| Earnings per Share | $8.27 |
| Beta | 0.83 |
| Outstanding Shares | 272,370,000 |
Return
| Return on Equity | 8.62% |
|---|---|
| Return on Assets | 4.65% |
| Return on Invested Capital | 9.78% |
Valuation & Multiples
| P/E Ratio | 25.76 |
|---|---|
| PEG | 42.58 |
| Price to Sales | 0.19 |
| Price to Book Ratio | 0.21 |
| Enterprise Value to Revenue | 0.45 |
| Enterprise Value to EBIT | 3.48 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 17, 2026
EPS Estimate
$0.22
Average shareholder expectationRevenue Estimate
$853.68 M
Average shareholder expectationNext Earnings Call
Expected Date
October 21, 2026
EPS Estimate
$0.25
Average shareholder expectationRevenue Estimate
$845.09 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Getinge AB (publ)
12,118 employees
CEO: Mattias Perjos Getinge AB (publ), established in Gothenburg, Sweden, in 1904, is a prominent global provider of advanced medical technology. The company specializes in delivering comprehensive products and integrated solutions tailored for operating ro...